ABSTRAL SUBLINGUAL TABLET 400 mcg
Product details
Registration number: SIN15150P
Classification: Prescription Only
Active ingredients: FENTANYL CITRATE (MICRONIZED) 628.4 μg eqv. FENTANYL
Strength: 400 µg
Dosage form: TABLET
Route: SUBLINGUAL
Registrant: A. MENARINI SINGAPORE PTE. LTD.
ATC code: N02AB03
HSA approval date: 6 January 2017
Manufacturer(s): RECIPHARM LEGANÉS S.L.U.
Manufacturing country/countries: SPAIN
What are the HSA registration number and classification for ABSTRAL SUBLINGUAL TABLET 400 mcg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15150P
Classification: Prescription Only
What active ingredients and strength are recorded for ABSTRAL SUBLINGUAL TABLET 400 mcg?
According to the HSA dataset updated 7 August 2026:
Active ingredients: FENTANYL CITRATE (MICRONIZED) 628.4 μg eqv. FENTANYL
Strength: 400 µg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ABSTRAL SUBLINGUAL TABLET 400 mcg?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET
Route: SUBLINGUAL
Who is the recorded registrant for ABSTRAL SUBLINGUAL TABLET 400 mcg?
According to the HSA dataset updated 7 August 2026:
Registrant: A. MENARINI SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for ABSTRAL SUBLINGUAL TABLET 400 mcg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): RECIPHARM LEGANÉS S.L.U.
Manufacturing country/countries: SPAIN
Where can I look up ABSTRAL SUBLINGUAL TABLET 400 mcg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15150P or the exact product name ABSTRAL SUBLINGUAL TABLET 400 mcg. The general register link does not preselect this product.
What are the source dates for this ABSTRAL SUBLINGUAL TABLET 400 mcg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ABSTRAL SUBLINGUAL TABLET 400 mcg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15150P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)